
Photo taken from
NCI CTEP Clinical Research/X
Jun 1, 2024, 12:11
Carlos Torrado: Excited to present our poster at ASCO24
Carlos Torrado, Clinical Fellow at MD Anderson Cancer Center, recently shared a post by NCI CTEP Clinical Research on X, adding:
“Excited to present our poster tomorrow at the ASCO meeting in collaboration with NCI CTEP!”
Quoting NCI CTEP Clinical Research’s post:
“ASCO24 abstract for ongoing ETCTN (10449).
Phase 1 study of BET inhibitor ZEN003694 in combination with MEK1/2 inhibitor binimetinib in solid tumors with RAS pathway alterations and triple-negative breast cancer”
Read further
Sources: Carlos Torrado/X and NCI CTEP Clinical Research/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:45
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45